Appointment of 5 New Trustees

Jun 17, 2020

We are absolutely delighted to share the appointment of 5 new members to the FH Europe Board of Trustees

The new Trustees, together with the existing ones, bring to the FH Europe Network a great diversity of experience and expertise areas. They represent understanding and voices of different stakeholders in our wider ecosystem, from patients to patient organisations’ leaders, FH clinicians and researchers, health policy makers, industry consultants, topic matter experts, innovators, entrepreneurs. Among them they represent 8 nationalities and speak English, Italian, Swedish, Romanian, Polish, Latvian, French and German. When planning the Board meetings, we will have to consider 4 different time zones. All of this while simultaneously reaching gender parity on the leadership team! A diverse board with a wide range of skills, experience and perspectives bolsters a charity’s resilience and gives it the best chance of fulfilling its purposes into the future.

Please join us in welcoming Samuel Gidding, Joanna Taylor, Marius Geantă, Dorota Zgódka and Giovanni Nisato.
Jules Payne, Chair of FH Europe, says ‘I am absolutely delighted at these 5 wonderful appointments and consider the executive team are shaped to move FH Europe onto the next level of its development. The Board of Trustees and our network of organisations, working together will be a formidable team’.

“I look forward to our collaboration with the Board, serving the international community of FH, HoFH, LP(a) and FCS patients and their loved ones. I am excited about the new chapter in the FH Europe book we will write together with the Network, ensuring that our work addresses the urgent public health priority and offers tangible solutions to save and improve lives we all represent and advocate for.” added Chief Executive of the organization, Magdalena Daccord.


FH Europe is registered as a charity; Charity number 1170731, registered in England and Wales.

FH Europe is registered as a charity; Charity number 1170731, registered in England and Wales.

FH Europe is supported by an educational grant from Amgen Limited, Sanofi, Regeneron, Akcea Therapeutics Inc. and Amryt
Site by: Vovi Web Design